Zyus - The Learning App

Photos

About College

The Gujarat Cancer & Research Institute (GCRI), established in the year 1972, is a functional autonomous body jointly managed by Government of Gujarat and Gujarat Cancer Society. It is also a Regional Cancer Centre of Government of India and getting assistance under National Cancer Control Programme. GCRI is a unique example of cooperation between State Government, Central Government and Non-Government Organization.The mission of the GCRI is to provide state-of-the art diagnostic and therapeutic services to the patients of all types of origin and financial background suffering from cancer. GCRI's scope also encompasses registering the tumor burden in the population, prevention through awareness drives, solving local medical problems through research and training of medical students as well as imparting knowledge to the medical fraternity. GCRI, with a multi-disciplinary close relationship between cancer care, research and education, intends to provide the greatest hope to the patients and the general population whose needs, we endeavour to cater to. It strives to see that fruits of modern science reach up to the last man.the GCRI is a largest cancer hospital of the country with union of best oncologists’ team with world class facilities for cancer diagnosis and treatment. The institute has three huge buildings which were intended to provide best and high standard health services and nursing care in all branches of oncology. This 650 bedded cancer hospital has taken excellent care of 25,905 new cases, 2,73,667 outdoor patients, 20,855 indoor admissions in 2011. For the patient care, the institute has total strength of 940 permanent employees in categories of class I, II and III officers (nursing), class IV employees and 110 resident doctors.

Contact Details

Civil Hospital Campus,
Asarwa,
Ahmedabad-380 016. Gujarat,
INDIA

director@gcriindia.org

+91-79- 2268 8000

Notifications

Reviews

Your Rating

Documents

Location

Ask Zyus

  • We are very glad to talk with you, please enter your message.